Literature DB >> 21575951

Responsiveness to metformin in girls with androgen excess: collective influence of genetic polymorphisms.

Marta Díaz1, Abel López-Bermejo, David Sánchez-Infantes, Judit Bassols, Francis de Zegher, Lourdes Ibáñez.   

Abstract

OBJECTIVE: To study the relationship between the responsiveness to metformin in girls with androgen excess and combinations of genetic variants-as reflected in a polymorphism score-in single nucleotide polymorphisms (OCT1, STK11, and FTO genes) and in the repeat numbers within the AR and SHBG genes.
DESIGN: Longitudinal (1-year) follow-up.
SETTING: University hospital. PATIENT(S): Hyperandrogenic adolescent girls receiving metformin. INTERVENTION(S): Single nucleotide polymorphisms and repeat numbers were assessed in 104 adolescent girls with androgen excess. The polymorphism score was the sum of subscores given for response alleles in OCT1, STK11, and FTO and for high repeat numbers in SHBG and AR alleles. MAIN OUTCOME MEASURE(S): The response to metformin (850 mg/d) was judged by changes over 1 year in endocrine-metabolic state and body composition. RESULT(S): Changes in fasting insulin levels, triacylglycerol levels, LDL-HDL ratio, and body composition differed strikingly by polymorphism score. CONCLUSION(S): Collectively, genetic polymorphisms had a major influence on the responsiveness to metformin in adolescent girls with androgen excess.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21575951     DOI: 10.1016/j.fertnstert.2011.04.075

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.

Authors:  Susan Sam; David A Ehrmann
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  Quantile-Dependent Heritability of Glucose, Insulin, Proinsulin, Insulin Resistance, and Glycated Hemoglobin.

Authors:  Paul T Williams
Journal:  Lifestyle Genom       Date:  2021-12-06

Review 3.  Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.

Authors:  Verónica Yumiceba; Andrés López-Cortés; Andy Pérez-Villa; Iván Yumiseba; Santiago Guerrero; Jennyfer M García-Cárdenas; Isaac Armendáriz-Castillo; Patricia Guevara-Ramírez; Paola E Leone; Ana Karina Zambrano; César Paz-Y-Miño
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-26       Impact factor: 5.555

4.  Hyperandrogenism and menstrual imbalance are the best predictors of metformin response in PCOS patients.

Authors:  Emanuele Garzia; Valentina Galiano; Giovanni Marfia; Stefania Navone; Enzo Grossi; Anna Maria Marconi
Journal:  Reprod Biol Endocrinol       Date:  2022-01-04       Impact factor: 5.211

5.  Hyperinsulinaemic androgen excess in adolescent girls.

Authors:  Lourdes Ibáñez; Ken K Ong; Abel López-Bermejo; David B Dunger; Francis de Zegher
Journal:  Nat Rev Endocrinol       Date:  2014-04-29       Impact factor: 43.330

Review 6.  Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.

Authors:  Miriam G Mooij; Anne T Nies; Catherijne A J Knibbe; Elke Schaeffeler; Dick Tibboel; Matthias Schwab; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

7.  Common Variants in 22 Genes Regulate Response to Metformin Intervention in Children with Obesity: A Pharmacogenetic Study of a Randomized Controlled Trial.

Authors:  Augusto Anguita-Ruiz; Belén Pastor-Villaescusa; Rosaura Leis; Gloria Bueno; Raúl Hoyos; Rocío Vázquez-Cobela; Miriam Latorre-Millán; M Dolores Cañete; Javier Caballero-Villarraso; Ángel Gil; Ramón Cañete; Concepción M Aguilera
Journal:  J Clin Med       Date:  2019-09-16       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.